⌘K

Login Start Free

Home/Filings/4/0001209191-12-027015

4//SEC Filing

VERTEX PHARMACEUTICALS INC / MA 4

Accession 0001209191-12-027015

$VRTXCIK 0000875320operating

View on SEC.gov Company Profile

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:36 PM ET

Size

15.8 KB

Accession

0001209191-12-027015

Insider Transaction Report

Form 4

Period: 2012-05-07

VERTEX PHARMACEUTICALS INC / MAVRTX

SVP, Human Resources

Transactions

Exercise/Conversion
Stock Option
2012-05-07−3,813→ 0 total
Exercise: $18.93Exp: 2018-02-06→ Common Stock (3,813 underlying)
Exercise/Conversion
Common Stock
2012-05-07$32.16/sh+3,813$122,626→ 60,981 total
Sale
Common Stock
2012-05-07$52.13/sh−7,187$374,658→ 37,552 total
Sale
Common Stock
2012-05-07$55.00/sh−16,242$893,310→ 44,739 total
Exercise/Conversion
Stock Option
2012-05-07−28,593→ 1,907 total
Exercise: $32.16From: 2008-10-24Exp: 2018-07-23→ Common Stock (28,593 underlying)
Exercise/Conversion
Common Stock
2012-05-07$32.16/sh+28,593$919,551→ 57,168 total
Sale
Common Stock
2012-05-07$57.50/sh−14,297$822,078→ 23,255 total

Holdings

Common Stock
(indirect: By 401(k))
1,667

Footnotes (2)

[F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
[F2]Fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeoperating

IncorporatedMA

Related Parties

1

filerCIK 0000875320

Filing Metadata

Form type: 4
Filed: May 8, 8:00 PM ET
Accepted: May 9, 4:36 PM ET
Size: 15.8 KB

View on SEC.gov